Curriculum Registration

Addressing the Challenges in the Multidisciplinary Care of Patients with High-Risk NMSC

Credits Available: 6.0 hours of AMA PRA Category 1 Credit™, 6.0 ACPE contact hours, MOC Points Available

Description: Non-melanoma skin cancers (NMSC) represent a class of heterogeneous cutaneous malignancies including basal cell carcinoma (BCC), cutaneous squamous cell carcinoma (cSCC), Merkel cell carcinoma (MCC), and rarer skin cancers. Accounting for one third of all cancer diagnoses, NMSCs are the most diagnosed malignancies in the world. It is estimated that 5 million BCCs and 1 million cases of SCC are diagnosed every year in the United States. Of these, high-risk SCC and BCC are relatively rare, while MCC, by its nature, is always considered high risk. Despite their relative rarity, high-risk NMSCs have a disproportionate impact on patient outcomes. The Gather-ed small group social learning platform will provide participating clinicians within each group with the opportunity, over a six-week period, to complete foundational materials asynchronously, and to engage with their colleagues and peers involved in the management of high-risk NMSC through live Group Leader-led synchronous interactions focused on areas of greatest concern of the group members, with peer-to-peer exchanges further encouraged in group case-based challenges.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:
Forgot Password

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Dermatology, Oncology, Plastic Surgery, Radiation Oncology, Mohs Surgery, Surgical Oncology

Emily Smith

SSM Health
Assistant Professor of Dermatology

Dr. Emily Smith is a board-certified dermatologist and dermatopathologist on faculty at the SSMC. She completed her dermatology residency and dermatopathology fellowship at the University of Michigan in Ann Arbor. Her clinical efforts are concentrated in the evaluation and management of complex cutaneous malignancies, including melanoma, high-risk nonmelanoma skin cancer and Merkel cell carcinoma, amongst others. She leads the multidisciplinary cutaneous oncology and oncodermatology program at Ellis Fischel Cancer Center. Her research efforts are focused on the early detection of skin cancer, using technology to improve early diagnosis, particularly for communities without access to dermatologic care. She is the principal investigator on multiple clinical trials for patients with complex cutaneous malignancies and serves on both national and international working groups and advisory committees helping to improve care for these patients. As a dermatopathologist, she employs her clinical skill in facilitating clinicopathologic correlation across a wide range of skin pathologies, from inflammatory to neoplastic conditions.